MedPath

Whole-genome sequencing and comprehensive variant analysis of combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC

Not Applicable
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000032493
Lead Sponsor
Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
600
Inclusion Criteria

Not provided

Exclusion Criteria

Cases in which written informed consent was not obtained

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The relation between the genomic mutation and the clinicopathological features in combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath